International workshop on lessons from animal models for human type 1 diabetes - Identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice
E. Bonifacio et al., International workshop on lessons from animal models for human type 1 diabetes - Identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice, DIABETES, 50(11), 2001, pp. 2451-2458
Several self-antigens have been reported as targets of the autoimmune respo
nse in nonobese diabetic (NOD) mice. The aim of this workshop was to identi
fy autoantibody assays that could provide useful markers of autoimmunity in
this animal model for type I diabetes. More than 400 serum samples from NO
D (4, 8, and 12 weeks of age and at diabetes onset), BALB/c, and B6 mice we
re collected from six separate animal facilities, coded, and distributed to
five laboratories for autoantibody measurement. Insulin autoantibodies (IA
A) were measured by radiobinding assay (RBA) by four laboratories and by en
zyme-linked immunosorbent assay (ELISA) in one laboratory. Using the 99th p
ercentile of BALB/c and B6 control mice as the threshold definition of posi
tivity, IAA by RBA were detected in NOD mice at frequencies ranging from 10
to 30% at age 4 weeks, from 26 to 56% at 8 weeks, from 42 to 56% at 12 wee
ks, and from 15 to 75% at diabetes onset. With ELISA, IAA signals differed
significantly between control mouse strains and increased with age in both
control and NOD mice, with frequencies in NOD animals being 0% at 4 weeks,
14% at 8 weeks, 19% at 12 weeks, and 42% at diabetes onset. For IAA, the EL
ISA results were relatively discordant with those of RBA. GAD autoantibody
(GADA) and IA-2 autoantibody (IA-2A) signals obtained by RBA were low (maxi
mum 2.5% of total) but were increased in NOD mice compared with control mic
e at diabetes onset (GADA 29-50%; IA-2A 36-47%). ELISA also detected GADA (
42%) and IA-2A (50%) at diabetes onset, with results concordant with those
of RBA. Remarkably, GADA and IA-2A frequencies varied significantly with re
spect to the source colony of NOD mice. Furthermore, whereas neither GADA n
or IA-2A correlated with IAA, there was strong concordance between GADA and
IA-2A in individual mice. Sera with increased binding to GAD and IA-2 also
had increased binding to the unrelated antigen myelin oligodendrocyte glyc
oprotein, and binding to GAD could not be inhibited with excess unlabeled a
ntigen, suggesting nonspecific interactions. In sum, this workshop demonstr
ated that IAA measured by sensitive RBA are a marker of autoimmunity in NOD
mice and draw into question the true nature of GADA and IA-2A in this anim
al model.